FOXO3 and cancer: The highest FOXO3a expression was observed in DOX and quercetin, as well as 5-FU and rutin co-treatments, coinciding with the lowest cell viability, suggesting that FOXO3a was involved in the cancer cell cytotoxicity by these treatments.